Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Lamarque

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|December 24, 2003
[Helicobacter pylori. Prevalence diminishes in industrialized countries]Dominique Lamarque
Bulletin Du Cancer|May 19, 2005
[Safety of selective cyclooxygenase-2 inhibitors taken for a long time]Dominique Lamarque
La Revue Du Praticien|April 8, 2014
[Treatment of Helicobacter pylori infection]Dominique Lamarque
Bulletin Du Cancer|July 9, 2004
[Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period]Dominique Lamarque
Gastroenterologie Clinique Et Biologique|September 16, 2004
[Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs]Dominique Lamarque
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Risk factors for upper digestive tract toxicity with NSAIDs (excluding Helicobacter pylori)]Dominique Lamarque, Stanislas Chaussade
Helicobacter|November 18, 2003
Pathogenesis of Helicobacter pylori infectionDominique Lamarque, Richard M Peek
Gastroenterologie Clinique Et Biologique|April 18, 2003
[What are the gastric modifications induced by acute and chronic Helicobacter pylori infection?]Dominique Lamarque, Jeanne Tran Van Nhieu, Maxime Breban
Methods in Molecular Biology (Clifton, N.J.)|May 29, 2003
Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel diseaseBrendan J R Whittle, Maryan Cavicchi, Dominique Lamarque
Inflammatory Bowel Diseases|July 12, 2011
First detection of Helicobacter canis in chronic duodenal ulcerations from a patient with Crohn's diseaseJacques Tankovic, Mounira Smati, Dominique Lamarque, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|December 24, 2003
[Helicobacter pylori. Prevalence diminishes in industrialized countries]Dominique Lamarque
Bulletin Du Cancer|May 19, 2005
[Safety of selective cyclooxygenase-2 inhibitors taken for a long time]Dominique Lamarque
La Revue Du Praticien|April 8, 2014
[Treatment of Helicobacter pylori infection]Dominique Lamarque
Bulletin Du Cancer|July 9, 2004
[Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period]Dominique Lamarque
Gastroenterologie Clinique Et Biologique|September 16, 2004
[Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs]Dominique Lamarque
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Risk factors for upper digestive tract toxicity with NSAIDs (excluding Helicobacter pylori)]Dominique Lamarque, Stanislas Chaussade
Helicobacter|November 18, 2003
Pathogenesis of Helicobacter pylori infectionDominique Lamarque, Richard M Peek
Gastroenterologie Clinique Et Biologique|April 18, 2003
[What are the gastric modifications induced by acute and chronic Helicobacter pylori infection?]Dominique Lamarque, Jeanne Tran Van Nhieu, Maxime Breban
Methods in Molecular Biology (Clifton, N.J.)|May 29, 2003
Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel diseaseBrendan J R Whittle, Maryan Cavicchi, Dominique Lamarque
Inflammatory Bowel Diseases|July 12, 2011
First detection of Helicobacter canis in chronic duodenal ulcerations from a patient with Crohn's diseaseJacques Tankovic, Mounira Smati, Dominique Lamarque, et al.
Pageof 6